• Director Merle Ferguson sold 26.7 million BioForce Nanosciences common shares on April 22, 2026 at USD 0.015.
• Holdings fell to zero shares following the sale.
• Ferguson also reported two April 20, 2026 gifts totaling 24.71 million shares at USD 0.007 and USD 0.001.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioForce Nanosciences Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001091818-26-000134), on September 02, 2026, and is solely responsible for the information contained therein.